The impact of prediabetes on glycemic control and clinical outcomes postburn injury
Amy Somerset1, Rebecca Coffey, Larry Jones
1From the *The Ohio State University College of Medicine, Columbus; and †Division of Trauma, Department of Surgery, and ‡Department of Pharmacy, Critical Care and Burn, The Ohio State University Wexner Medical Center, Columbus.
Insights
Prediabetes significantly impacts glucose control and survival rates in burn patients. This condition leads to higher inpatient glucose levels and increased mortality compared to euglycemic controls.
Area of Science:
- Metabolic disorders and critical care medicine
- Endocrinology and trauma research
Background:
- Poor glucose control and adverse clinical outcomes are documented in diabetic patients postburn injury.
- Prediabetes, a precursor to diabetes, represents a critical window for intervention and study in patient populations.
Purpose of the Study:
- To investigate the effects of prediabetes on post-burn injury glucose control.
- To assess the impact of prediabetes on clinical outcomes following burn injuries.
Main Methods:
- Retrospective review comparing prediabetic patients (HbA1c 5.7-6.4%) with euglycemic controls (HbA1c < 5.7%).
- Inclusion criteria: burn care admission, age 18-89 years, and admission hemoglobin A1c (HbA1c) measurement.
- Data collected included inpatient glucose levels and clinical outcomes; 208 patients were analyzed (54 prediabetics, 154 controls).
Main Results:
- Prediabetic patients were older, had higher rates of hypertension, were more often African-American, and sustained larger full-thickness burn areas.
- Prediabetics exhibited significantly higher time-weighted glucose levels and a greater incidence of average inpatient glucose >150 mg/dl.
- While no differences in hypoglycemia or glycemic variability were observed, prediabetics showed lower survival rates (92.6% vs 98.7%).
Conclusions:
- Prediabetic status significantly impairs glucose control following burn injury.
- Prediabetes is associated with increased mortality after burn injury, despite similar rates of readmission, ICU admission, and infection.
- Early identification and management of prediabetes in burn patients may be crucial for improving outcomes.
Abstract:
Poor glucose control and clinical outcomes have been observed in diabetic versus nondiabetic patients postburn injury. Prediabetes is a precursor to diabetes. The purpose of this study was to assess the effects of prediabetes on postinjury glucose control and clinical outcomes. A retrospective review was conducted comparing prediabetics and euglycemic controls. Patients who were admitted for burn care were 18 to 89 years of age and had a hemoglobin A1c (HbA1c) obtained on admission. Prediabetics were defined by an HbA1c of 5.7 to 6.4% and controls by HbA1c < 5.7%. Inpatient glucose levels were recorded, in addition to clinical outcomes. Two hundred eight patients were included: 54 prediabetics and 154 controls. The prediabetic population was older (50.7 vs 39 years; P < .001) with more hypertensives (44.4 vs 16.9%; P < .001), consisted of more African-Americans (20.4 vs 12%; P = .04), and had larger areas of full-thickness burns (4.5 vs 1.75%; P = .02). Median admission HbA1c was 5.9 (5.7-6.0)% among prediabetics and 5.3 (5-5.45)% among controls (P < .001). Prediabetics had significantly higher time-weighted glucose levels (127.7 [105.5-147.6] vs 108.0 [97.1-122.2] mg/dl; P < .001) and more had an average inpatient glucose >150 mg/dl (20.4 vs 9.1%; P = .028). There was no difference in rates of hypoglycemia (glucose <70 mg/dl) or glycemic variability. Prediabetics had lower survival rates (92.6 vs 98.7%; P = .041), but similar rates of unplanned readmission (1.9 vs 3.9%; P = .68), intensive care unit admission (29.6 vs 23.4%; P = .36), mechanical ventilation (24.1 vs 16.2%; P = .20), length of hospital stay (4 [2-8] vs 3 [2-11]; P = .71), and infection (11.1 vs 11.7%; P = .99). Prediabetic status has a significant impact on glucose control and mortality after burn injury.
Related Concept Videos
Hyperglycemia
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes II: Pathophysiology
Diabetic Foot Ulcer
Complications of Diabetes Mellitus


